Allsop Propchat

Allsop Propchat: How Alport UK charity selection aligned firm interests and advanced rare kidney disease research

30 min Listen to the original Episode page
Rare DiseasesCharityHealthcarePhilanthropyAlport SyndromeClinical TrialsGlobal HealthFundraising

Summary

George Walker and Will Shoebotham of Allsop Propchat discuss how their investment team's internal competition to select a charity led to the choice of Alport UK, a rare kidney and hearing disease charity. Susie Gear, CEO of Alport UK, describes the charity's 'kitchen table' operational model and its progress from zero pharmaceutical interest 12 years ago to facilitating eight clinical trials and twelve preclinical treatments by 2026. Patrick Walker shares his personal experience with Alport syndrome, highlighting the severe impact on kidneys, hearing, and eyes typically manifesting in early adulthood. The episode details the growth of the Alport Syndrome Alliance workshop in Budapest, which attracted 258 attendees from 40 countries, fostering global collaboration among patients, clinicians, and pharmaceutical representatives. Will Shoebotham highlights the generosity of Allsop's clients and staff, citing significant fundraising efforts that strengthened internal bonds and supported the charity.

Key takeaways

  1. 1
    Alport research has progressed from zero pharmaceutical interest 12 years ago to having 8 clinical trials reporting and 12 innovative treatments in preclinical stages by 2026.

    Susie Gear · 6:29

  2. 2
    Allport syndrome is a condition that affects the kidneys, ears and a little bit of eyes. It's uh generally hits around the age of university. So we're talking eighteen to to twenty-five twenty five is when people start getting really severe. enough symptoms that they then require a kidney transplant.

    Will Shoebotham · 7:45

  3. 3
    Budapest was our 10th international workshop, and they were really small, so 70 people in a room to start with. In Budapest, we had 258 people from 40 forty countries.

    Susie Gear · 14:58

Episode sections

  1. 0:03 – 5:10

    Introduction and Charity Selection

    George Walker introduces the podcast's focus on Allsop's chosen charity, Alport UK, a rare kidney and hearing disease charity. He introduces Will Shoebotham, who explains that Allsop's investment team won a competition to choose the charity, driven by personal connections to kidney disease within the team.

  2. 5:10 – 7:41

    Alport UK Overview and Research Progress

    Susie Gear, CEO of Alport UK, describes the charity as a tiny, 'kitchen table' operation with no offices, relying on a global network. She notes that while the charity started 12 years ago with no pharmaceutical interest, it has facilitated 8 clinical trials and 12 preclinical treatments showing positive results by 2026.

  3. 7:41 – 14:05

    Patient Experience and Medical Impact

    Patrick Walker details Alport syndrome's impact on kidneys, hearing, and eyes, typically manifesting severely in early adulthood. He discusses the challenges of hearing aids from age eight, the timing of his kidney transplant during the pandemic, and the lifestyle adjustments required post-transplant.

  4. 14:05 – 18:18

    Global Collaboration in Budapest

    Susie Gear explains the Alport Syndrome Alliance's annual workshop, which brings together patients, clinicians, scientists, and pharma representatives. The 2026 event in Budapest saw 258 attendees from 40 countries, marking a significant increase from the initial 70 attendees in Oxford.

  5. 18:18 – 23:59

    Fundraising and Community Engagement at Allsop

    Will Shoebotham highlights the generosity of Allsop's clients and staff, citing a £10,000 donation at a spinning class. He describes endurance challenges like a 100km walk in the Yorkshire Dales during severe weather, which strengthened internal bonds and raised significant funds for the charity.

  6. 23:59 – 24:36

    Raising Awareness and Diagnosis Rates

    Susie Gear explains that Alport syndrome is more common than perceived, affecting 1 in 100 people with a genetic variant, but low awareness hinders diagnosis. Fundraising efforts help raise the profile of the disease to ensure more people get diagnosed.

  7. 24:36 – 25:35

    Patient Storytelling and Global Collaboration

    Allsop funded films created by a filmmaker to illustrate life with Alport syndrome, filmed in Italy, Hungary, and Spain. These videos help explain the disease across different health systems and countries.

  8. 25:35 – 26:49

    Genetic Testing as a Policy and Diagnostic Tool

    George Walker and Susie Gear discuss how genetic testing is critical for diagnosing Alport and other rare kidney diseases. They highlight efforts to integrate genetic testing into public health systems in countries like Singapore and Australia.

  9. 26:49 – 28:07

    Cross-Border Research and Treatment Development

    Susie Gear describes collaboration between countries, such as an Indonesian researcher sending samples to Japan for testing. This global network accelerates diagnosis and management of the science behind the disease.

  10. 28:07 – 29:38

    Pharma Interest and Broader Therapeutic Impact

    A Swedish pharma company expressed interest in Alport treatments because many are not specific to Alport but could also help other rare diseases and transplanted kidneys, expanding the potential impact of the research.

Claims worth verifying

Allsop's investment team won a competition to choose Alport UK as the charity of the year for 2026.

Unidentified speaker (UNKNOWN) ·2:47

How to verify: Internal Allsop communications or press releases regarding their 2026 charity partnership; verify via Allsop's official website or LinkedIn page. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Alport UK has been operating for 12 years, starting with a workshop in Oxford where there was no pharmaceutical interest.

Unidentified speaker (UNKNOWN) ·6:22

How to verify: Alport UK's official website history section or annual reports; verify via the charity's registered address and public filings in the UK. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Primary source

As of 2026, there are 8 clinical trials reporting and 12 innovative treatments in preclinical studies for Alport syndrome.

Susie Gear ·6:29

How to verify: ClinicalTrials.gov search for 'Alport Syndrome' status 'Recruiting' or 'Active, not recruiting'; verify via the Alport Syndrome Alliance website or press releases from participating pharma companies. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

The 2026 Alport workshop in Budapest had 258 attendees from 40 countries.

Susie Gear ·14:58

How to verify: Alport Syndrome Alliance 2026 workshop report or press release; verify via the organization's official website or social media announcements. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Patrick Walker received a kidney transplant in 2020 during the COVID-19 pandemic.

Will Shoebotham ·8:49

How to verify: Patrick Walker's public social media posts or Alport UK patient stories; verify via NHS transplant records if publicly disclosed or through patient advocacy group archives. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

A scientist flew 30 hours from Japan to attend the Budapest workshop for a single session.

Unidentified speaker (UNKNOWN) ·17:04

How to verify: Attendee lists or session schedules from the 2026 Alport workshop; verify via the Alport Syndrome Alliance conference materials. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Allsop's Leeds office team completed a 100km walk in 24 hours in the Yorkshire Dales during severe weather.

Unidentified speaker (UNKNOWN) ·20:47

How to verify: Allsop's social media posts (LinkedIn/Facebook) featuring the event; verify via local news coverage in Leeds or Yorkshire Dales. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

A client donated £10,000 at an Allsop charity spinning class.

Unidentified speaker (speaker_3) ·20:22

How to verify: Allsop's fundraising reports or social media updates; verify via the charity's acknowledgment of donations or Allsop's internal newsletters. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Alport syndrome typically hits severely around age 18-25, requiring kidney transplants.

Unidentified speaker (UNKNOWN) ·7:45

How to verify: Medical literature on Alport syndrome onset and progression; verify via peer-reviewed journals such as the Journal of the American Society of Nephrology. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Indonesia lacks widespread genetic testing for Alport syndrome.

Unidentified speaker (UNKNOWN) ·19:01

How to verify: Healthcare infrastructure reports or Alport UK's global patient mapping data; verify via World Health Organization (WHO) data or Alport UK's patient engagement reports. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Alport syndrome affects 1 in 100 people in any population who have a genetic variant.

Unidentified speaker (UNKNOWN) ·24:22

How to verify: Peer-reviewed medical literature or Alport UK patient statistics; verify via medical journals or Alport UK website publications. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Allsop funded the creation of four videos about living with Alport syndrome.

George Walker ·25:14

How to verify: Check Alport UK website or podcast episode notes for the videos; verify corporate sponsorship records if available. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Films about Alport syndrome were produced in Italy, Hungary, and Spain.

Susie Gear ·25:20

How to verify: Review the video content or production credits on Alport UK’s media channels. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Singapore has implemented genetic testing for Alport syndrome as part of public policy.

George Walker ·25:41

How to verify: Singapore Ministry of Health publications or academic papers on genetic testing adoption in Singapore. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

A professor in Australia successfully got genetic testing agreed upon by the government.

Susie Gear ·26:20

How to verify: Australian government health department records or academic publications citing the professor’s advocacy. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

A Swedish pharma company stated that Alport treatments may help transplanted kidneys.

Susie Gear ·28:07

How to verify: Press releases from the Swedish pharma company or clinical trial registries listing indications. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Allsop clients contributed to fundraising efforts for Alport UK.

Unidentified speaker (UNKNOWN) ·29:12

How to verify: Allsop or Alport UK fundraising reports for the relevant period. For recent events, verify 2026-08-05 through 2026-11-05. Use another period only when the speaker explicitly names it.

Do your own research

  • Verify the current number of clinical trials and preclinical treatments for Alport syndrome via ClinicalTrials.gov or Alport UK's official reports.
  • Check the attendance records and attendee demographics for the 2026 Alport Syndrome Alliance workshop in Budapest through the Alliance's official website or press releases.
  • Review Alport UK's financial statements and annual reports to confirm the 'kitchen table' operational model and staff count of four.
  • Investigate the genetic prevalence of Alport syndrome (1 in 100) through peer-reviewed medical journals or genetic databases like OMIM.
  • Assess the availability of genetic testing for Alport syndrome in low-resource settings like Indonesia via WHO reports or local health ministry publications.
  • Examine the spillover benefits of Alport treatments for other rare diseases and transplanted kidneys by reviewing pharmaceutical company press releases or scientific publications.
  • Verify Allsop Propchat's client donation records and fundraising totals through their official charity partnership announcements or annual impact reports.
  • Check for any conflicts of interest between Allsop Propchat and pharmaceutical companies involved in Alport research by reviewing their public disclosures or regulatory filings.
Full transcriptexpand
0:03
George Walker: Welcome everybody to the latest edition of the Ulsop Prop Chat. My name is George Walker, one of the commercial auctioneers at Allsopps. Today is a bit different. We are going to cover
0:13
Unidentified speaker (UNKNOWN): the
0:13
George Walker: Allsop charity of the year, which is actually confusingly called Allport. Allport is a rare kidney and hearing disease charity in the UK. Around me, I've got volunteers and patients, so I'll crack on and introduce the first of those. So, first on my list today is Will Shoebotham. So you are day-to-day an agent. How are you involved with Allport?
0:33
Will Shoebotham: Hi, yeah. So, Will Shoebotham partner in the Resident Investment team at AllSop. What we've been doing at AllSop is we have been sponsoring a charity each year, and uh this year we we chose that Allport was the charity that we're going to sponsor. And I actually have a family member as well that's sort of been impacted by a rare disease which is is kidney related
0:53
Will Shoebotham: as well. So uh since the start of the year I've sort of been very invested in the in the charity and um yeah we've been raising lots of money and more recently uh volunteered at a workshop in Budapest.
1:03
George Walker: Uh Susie and I have to confess Susie and I will have been married 35 years in December which partly explains why she's here. But
1:10
George Walker: also one of the world's experts on Allport. aw port so
1:13
Unidentified speaker (UNKNOWN): talk
1:13
George Walker: us through it.
1:14
Susie Gear: Thank you. Uh Susie Gear, I'm Chief Executive of Allport UK. I'm also facilitator of the Allport Syndrome Alliance, uh, which is a global network that's advancing treatments and knowledge. But also my mother was diagnosed with all port over 50 years ago
1:34
Susie Gear: now, and I was misdiagnosed because I had such mild ALP. ulport, but uh many members of my family are impacted. Uh but thankfully, uh, because of my mild ulport, I was actually allowed to donate a kidney to our youngest son, Jamie, two years ago.
1:51
George Walker: You so you gave a kidney to Jamie, who is now he has three kidneys and he's skiing and dancing and having a great time. That's two years ago. And keeping in the family, Patrick.
2:00
Will Shoebotham: So I'm your son. I did not get
2:03
Unidentified speaker (UNKNOWN): a kidney
2:03
Will Shoebotham: from mum. That revelation came after I got my kidney about six years ago now during COVID. Otherwise, I'm a patient and volunteer with Oldport, UK.
2:14
Unidentified speaker (UNKNOWN): And
2:14
George Walker: your day-to-day world? You're London based?
2:16
Will Shoebotham: So I work in strategic communications and public affairs, and my day job has really nothing to do with the condition at all. I go out on the weekends, I drink, I do everything.
2:27
Will Shoebotham: you know that you would expect from a 28-year-old in London. Um, but I volunteering with Allport UK has been one of the greatest privileges of my life.
2:37
George Walker: So, Will, um, charity of the year. I mean, how
2:41
Unidentified speaker (UNKNOWN): all
2:41
George Walker: sorts of got about 220 people all across the UK. How do you choose a nominated charity?
2:47
Unidentified speaker (UNKNOWN): Yeah,
2:47
Will Shoebotham: so look, I think so. This started with all Allsop sorts of last. last year when we were uh raising money for a charity called The Cycle. And I think it's the first time that we at AllSOP had actually a specific charity that we were raising money for each year. And the idea was that each of the teams within Allsop, we've probably got about ten to twelve, were sort of fundraising throughout the year and whoever
3:07
Will Shoebotham: whichever team raised the most money got to choose which charity we supported the following year. So it sort of had that competitive
3:13
Unidentified speaker (UNKNOWN): So you
3:13
George Walker: were the winners last year. Yeah, yeah,
3:15
Unidentified speaker (UNKNOWN): quite.
3:15
Will Shoebotham: So as
3:15
Unidentified speaker (speaker_3): soon as there's
3:16
Unidentified speaker (UNKNOWN): a
3:16
Unidentified speaker (speaker_3): competitive
3:17
Will Shoebotham: edge uh thrown
3:18
Unidentified speaker (UNKNOWN): in the mix,
3:19
Unidentified speaker (speaker_3): it it sort
3:19
Will Shoebotham: of rolls
3:20
Unidentified speaker (speaker_3): everyone up. And I think from our point of view, as I say, I work in the investment team where we
3:25
Unidentified speaker (UNKNOWN): got
3:25
Unidentified speaker (speaker_3): development and student as well, and
3:27
Unidentified speaker (UNKNOWN): we
3:27
Unidentified speaker (speaker_3): were pretty passionate about winning because I think we wanted to support a charity which
3:33
Will Shoebotham: in
3:33
Unidentified speaker (speaker_3): effect
3:34
Will Shoebotham: helped with sort of
3:35
Unidentified speaker (speaker_3): kidney disease. I think as a team we had various members as we sort of spoke about it, had been sort of affected by kidney disease. Boydie, who's a senior partner and runs the team, his father-in-law had been affected. He's
3:47
George Walker: got a kidney transplant, hasn't he?
3:49
Unidentified speaker (speaker_3): Yeah, his father-in-law, I think, had two throughout his life. Yeah. Laura, who's in the team, her granddad had been affected. And also my nephew, he he he suffers from a rare disease. And when he was probably about seven or eight, and they found a tumour on one of his kidneys, he had to go through all the chemo and ended up having the kidney out and then being left with half a kidney and then probably a few years later
4:09
Unidentified speaker (speaker_3): uh had a kidney transplant from his his his dad. So
4:12
George Walker: just to be clear, so so Charlie's had you know a
4:15
Unidentified speaker (UNKNOWN): a
4:15
George Walker: very rare kidney disease and his dad stepped up was it twelve months ago?
4:20
Unidentified speaker (UNKNOWN): Well no, it's a lot of it. It was
4:21
Unidentified speaker (speaker_3): during COVID actually, so it was through in an the you know an extra ex extra uh sort of complication. So it was it was a good few years ago now. And
4:29
George Walker: has Charlie settled down? Is it has the hell
4:31
Unidentified speaker (UNKNOWN): settled down? I
4:32
Unidentified speaker (speaker_3): mean as as you know, it's a constant roller coaster, right? So you don't get a new kidney and then the next day you're sort of up and about and running around. So you've got your ups and your downs. But you know, he's a fourteen year old lad who's playing football four, five times a week. And
4:46
George Walker: Villa won the cup, so too.
4:47
Unidentified speaker (speaker_3): and Villa won the cup last season, so he's absolutely loving life.
4:50
George Walker: Life isn't too bad.
4:51
Unidentified speaker (speaker_3): So look, we were really passionate about
4:53
Unidentified speaker (UNKNOWN): doing
4:53
Unidentified speaker (speaker_3): something that's kidney related, and then obviously the link with yourselves, George, Susie, Patrick, Allport, it was just a no-brainer for us. And because you're a small charity as well. So we know that every penny that we're raising this year is It's going gonna to make a difference.
5:10
Unidentified speaker (UNKNOWN): So
5:11
George Walker: Susie, I mean we all know there's quite a bit of impact. How small is Orport UK? I mean, is it on a scale? Have you got office buildings and things like that? Create a picture of what people see of this massive impact you have around the world.
5:23
Susie Gear: Oh yes. Basically we call ourselves small but mighty. So we we are tiny groups, so there's four of us, and we sit round kitchen tables or we're online. So we have no office buildings. Right. Uh we basically hold our meetings wherever we are. But we have this huge mighty agenda because when you work on a rare
5:42
Susie Gear: disease you there aren't enough people in the UK to make it interesting enough for pharmaceutical companies to kind of get interested and develop treatments. So what you have to do is to kind of join people up around the world. So actually our agenda has been about engaging people in all the large populations. You know so we
6:02
Susie Gear: start started with China 12 years ago. So when we set up, because it's a big population. Yep. Um, so we've got an amazing group in China. So it it's we're a really tiny charity doing this work. So every penny, you know, goes towards um supporting patients. So
6:18
Unidentified speaker (UNKNOWN): you've been
6:18
George Walker: going 12 years, so um one assumes that the the work you do compounds over those years. I mean,
6:22
Unidentified speaker (UNKNOWN): yeah
6:22
George Walker: where where are you now compared to twelve 12 years ago?
6:25
Susie Gear: Oh god, I mean uh well. Well,
6:27
George Walker: where is all port research compared to 12 years ago?
6:29
Susie Gear: Yeah, so uh 12 years ago we organized our first workshop in Oxford. There were no pharmaceutical companies interested, no treatments. This year in Budapest uh we had eight clinical trials reporting, and we've got about 12 For really different innovative treatments that are in showing positive results
6:49
Susie Gear: in preclinical studies. which is amazing.
6:52
George Walker: And you know the world of clara uh passing drugs through the system is quite complicated. So the first stage, as I understand, is clinical trials. Have you got any therapies in clinical trials at the moment?
7:02
Susie Gear: So we've got um a whole range of therapies and clinical trials. So all port patients are being engaged in those and some of them are showing really positive results too.
7:11
George Walker: And is that largely because of the the work and the facilitation you've done for the last decade?
7:15
Susie Gear: Yeah, so basically we're a tiny team, but we work with a massive group of volunteers. So I have 32 professors that I jump on a call with once a month, and they're coordinating efforts all around the world in research and with pharma companies, and they're the ones that are developing the treatments. So it it's a massive network that's
7:34
Susie Gear: developing the treatments
7:35
Unidentified speaker (UNKNOWN): now.
7:36
George Walker: So, Patrick, we haven't even really described what all Allport does as a as a patient.
7:41
Unidentified speaker (UNKNOWN): Let's do that. Give
7:41
George Walker: us the elevator pitch. What is it? How does it impact you and how do you deal with it?
7:45
Unidentified speaker (UNKNOWN): So
7:45
Will Shoebotham: Allport syndrome is a condition that affects the kidneys, ears and a little bit of eyes. It's uh generally hits around the age of university. So we're talking eighteen to to twenty-five twenty five is when people start getting really severe. enough symptoms that they then require a kidney transplant.
8:05
Will Shoebotham: And
8:06
George Walker: deafness, when does that kick in?
8:07
Will Shoebotham: Deafness. So I uh speaking from my own experience, I've been hard of hearing since I was eight, I've worn hearing aid since then. Um I think
8:14
George Walker: the first set had Liverpool F C on them, didn't
8:16
Unidentified speaker (UNKNOWN): they?
8:16
Will Shoebotham: Th you're thinking of my brother. But
8:20
Will Shoebotham: th th it's a real challenge when you're when you're that young because obviously you you're wearing something like that that you've associated with older people for as long as you've known them, you've seen them on older people's ears, and suddenly you're having to wear them. You want something colourful, you want little designs on the insides of the molds, you want
8:38
Unidentified speaker (UNKNOWN): different
8:39
Will Shoebotham: weird colours and that kind of thing. It's the one way of personalizing it. Anyway, look, we're getting off track. Point
8:44
Unidentified speaker (UNKNOWN): is so
8:45
George Walker: we're done hearing it f fails quite early. So
8:47
Unidentified speaker (UNKNOWN): I heard
8:48
George Walker: talk us through the kidney thing.
8:49
Will Shoebotham: So my kidney transplant. transplants happened in when I was I was in my fourth year of university doing my masters. I was called in to have a transplant about two days before New Year, uh in twenty twenty, I think.
9:08
Unidentified speaker (UNKNOWN): Four in the morning, yeah,
9:09
Will Shoebotham: absolutely. I I've been up drinking for a COVID quiz the night before. As ma as many people I'm sure will remember. Um so the the point really with k this particular form of kidney disease, and your nephew will relate to this, is that it comes at the particular time when you really don't want to be out. You don't want to be taking a break from your life. You don't want to be taking a
9:29
Will Shoebotham: break from your studies. Because
9:30
George Walker: you've probably got GCSEs done, but you might be A levels then and it's your degree if you're good, go on.
9:34
Will Shoebotham: Of course. We talk about university being the the best three years of your life in some cases, and you're prevented from doing all of that. Well, it makes it a lot tougher to do all of that because you're having to deal with this stupid disease on the on the side. It's a it's a lot of time in the hospital, it's a variety of different drugs and medications and it takes
9:54
Will Shoebotham: up
9:54
Unidentified speaker (UNKNOWN): a lot of heads. Time in
9:55
George Walker: hospital dialysis. Did you do Do dial dialysis?
9:58
Unidentified speaker (UNKNOWN): So
9:58
Will Shoebotham: dialysis is required for a lot of patients. I managed to dodge it by getting
10:01
Unidentified speaker (UNKNOWN): how
10:01
George Walker: restrictive is dialysis?
10:04
Will Shoebotham: So dialysis happens with a quite a lot of patients and it can have a huge impact on your life. It's manageable. So my brother Jamie has managed to dialyse while at university and doing all of the incredible things that you'd expect from a normal student at university. But it's a huge impact on your life. Either you're dialysing at home and and that can affect your sleep a little bit, or
10:23
Will Shoebotham: you're going into hospital and again you're surrounded by people that are double your age, triple your age.
10:29
Unidentified speaker (UNKNOWN): All
10:30
George Walker: bright yellow and sort of slow-moving people.
10:32
Will Shoebotham: Totally. And it's difficult from that perspective to then jump back into your normal life.
10:37
George Walker: You've got your your second kidney, your third kidney. There's a little anomaly there. And
10:43
Unidentified speaker (UNKNOWN): talk
10:43
George Walker: us through. I mean, is that how destructive is that? I mean, are you able to do exercise what's your diet exercise plan like? Is it different? Is it is it kidney focused or is it patrick focused?
10:52
Will Shoebotham: So the wonderful thing about support from Hallport UK and indeed from the incredible clinicians at the NHS is that once you have the kidney transplant and you've overcome the roller coaster, as Shubo said, you are free to live your life. So I'm a a big party, I'm out over the weekends. Um
11:12
Will Shoebotham: But
11:12
George Walker: you do rattle. I mean, you there's a lot of pills going down there.
11:14
Will Shoebotham: Yeah, is a lot of pills going down. I think if I had to pull out something that I'm better at than most people at, it's taking a lot of pills very quickly. Sunday
11:22
Unidentified speaker (UNKNOWN): night
11:22
George Walker: is the pill sort out night, which is quite a big deal. Is it carrier bags full?
11:25
Will Shoebotham: Once you've got your kidney transplant, in theory, it's just quite a lot of hospital visits, it's a lot of headspace, keeping track of all of those medications. But for some people it can be really isolating because you've got this condition that are not a a lot of. young people have. You are constantly uh looking for ways to relate to
11:45
Will Shoebotham: people. And that's where Allport UK comes in in terms of you connecting me with other patients that have the condition and not just supporting medical trials but getting patients together and enabling us to have a proper conversation about it.
12:00
Unidentified speaker (UNKNOWN): So
12:00
George Walker: Susie, how how does the
12:01
Unidentified speaker (UNKNOWN): Allport
12:02
George Walker: Orport UK
12:03
George Walker: support the network? I mean is there it must be social media and things like that.
12:11
Susie Gear: Yeah well so the big thing is for families to connect with us in the first place because often they're so nervous and just dealing with living with a kidney disease.
12:21
Unidentified speaker (UNKNOWN): And how rare where is it?
12:22
George Walker: Will will a will a family, you know, in Bedfordshire know another family in Bedfordshire
12:26
Unidentified speaker (UNKNOWN): No,
12:26
Susie Gear: not no no.
12:27
Unidentified speaker (UNKNOWN): Often
12:27
Susie Gear: you've never met anybody else with the condition. I think you uh Will you had that with your family, didn't you? Never met anybody else with the same condition
12:35
Unidentified speaker (UNKNOWN): at all. Because
12:36
Unidentified speaker (speaker_3): no
12:36
George Walker: Charlie's is a is a rare disease.
12:38
Unidentified speaker (UNKNOWN): So
12:39
George Walker: learning more about it is that helpful?
12:40
Unidentified speaker (speaker_3): Well, yeah, I think like so for me, because it is such a rare disease, you you really don't know much about it at all. And yeah, Susie put me in touch with this you know lovely French guy who he's a specialist in that field. And you know, it's just a ten minute conversation with him. It's certain questions that you you have and you haven't been able to ask anyone before, he actually sort
13:00
Unidentified speaker (speaker_3): of puts you at ease a lot because he's like, Whilst it is a rare disease, it's his day job, and he can sort of just you know
13:07
Susie Gear: and he really understands it,
13:08
Unidentified speaker (UNKNOWN): doesn't he? Yeah, and and
13:09
Unidentified speaker (speaker_3): yeah, so he's meeting people with the rare rare air disease on a daily basis,
13:13
Unidentified speaker (UNKNOWN): but
13:13
Unidentified speaker (speaker_3): you will never have met anyone before who has any even the s smallest inkling as to sort of what he might have been through and what the future holds, etcetera. So you know
13:22
Unidentified speaker (UNKNOWN): Does that
13:22
George Walker: help your family deal with the
13:24
Unidentified speaker (speaker_3): Yeah, I think so because uh often it's the not knowing, I suppose, which you know gives you the anxiety or probably gave me the anxiety, but you know, these five ten minute chats, That's you know, are hugely beneficial and you know, off the back of that and putting him in touch with the family and he was only too willing to want to help really. Which
13:42
George Walker: is great.
13:43
Unidentified speaker (UNKNOWN): And
13:43
Unidentified speaker (speaker_3): you yeah, you get a lot out of that. And
13:45
Unidentified speaker (UNKNOWN): I
13:45
Unidentified speaker (speaker_3): mean we'll get into Budapest, but when I saw on the first day when we had the patients there and you seemed
13:52
George Walker: on
13:52
Unidentified speaker (speaker_3): my
13:52
George Walker: jumpest, what we're talking about here.
13:56
Will Shoebotham: Wild night the wild night out that we thought
13:58
Unidentified speaker (UNKNOWN): you gave it.
14:00
George Walker: I think looking at Suji's Susie's eyes is three hard days. Summarize Budapest. What does that actually be
14:04
Unidentified speaker (UNKNOWN): at the moment?
14:05
Susie Gear: So Budapest is the global network coming together in person once a year. So we've been doing this. We started in Oxford.
14:12
George Walker: Network of what?
14:13
Susie Gear: So it's a network, good question. Network of people living with Auport.
14:17
George Walker: So patients.
14:18
Susie Gear: Patients, clinicians, uh so people looking after patients. So children's kidney doctors, adult kidney doctors, geneticists, and then laboratory. scientists. So they're the people who are looking down the microscopes, trying to understand at a molecular level what's happening to the kidney and making it fail. Pharmaceutical companies, so we
14:38
Susie Gear: get representatives from pharma companies. So they are the scientists who work in the companies or the company representatives who are designing clinical trials, and then other people from regulatory authorities like. the European Medicines Agency. So we get all these different disciplines in the room together, and we do it once a year. So
14:58
Susie Gear: Budapest was our 10th international workshop, and they were really small, so 70 people in a room to start with. In Budapest, we had 258 people from 40 forty countries.
15:11
George Walker: Good lord. And Will,
15:13
Unidentified speaker (UNKNOWN): what
15:13
George Walker: does did it feel like to you? Europe You're is a as as a patient and a volunteer?
15:16
Unidentified speaker (UNKNOWN): Talk
15:17
George Walker: us through your what do you think of the impact?
15:18
Unidentified speaker (speaker_3): Yeah, so I I didn't really have any expectations and just sort of turned up and you know, see what it was like. And I was I was taken back. So the first day it was sort of more patient focus, wasn't it? And
15:29
Susie Gear: yeah, patient information.
15:31
Unidentified speaker (speaker_3): So, you know, that first couple of hours where we're all sat in a circle and everyone has an opportunity sort of to tell their story
15:38
Unidentified speaker (UNKNOWN): why
15:38
Unidentified speaker (speaker_3): they're there. And it's from people all over the world and Europe. And
15:43
Unidentified speaker (UNKNOWN): I
15:43
Unidentified speaker (speaker_3): think it's probably for the first time for a lot of those people in that room have met someone else who's going through their struggles and are at different points as well. So, like there was a family from Hungary who I think one of their children was on dialysis at that point in time, and it was really emotional, and the poor mother sort of broke down in tears. But you've also got a
16:03
Unidentified speaker (speaker_3): chap there who's probably on it, I think, on his first or second transplant, and he's the hundred-meter transplantee world champion. So you get to see that whilst
16:14
George Walker: 10.9 seconds.
16:15
Unidentified speaker (UNKNOWN): Yeah,
16:15
Unidentified speaker (speaker_3): I mean, we're going so one family is going through this at the moment, but look what where it can be in a few years. It's n it's this isn't something that needs to completely overtake your life. You know, there is a you know, there are lights through the trees, so to speak. So yeah, I mean I and and then it moves into the sort of the more uh the clinicians and sort of
16:35
Unidentified speaker (speaker_3): researchers and and even just seeing those guys sort of having the first opportunity where someone in Beijing may have been working on, you know, the same element of research as someone in South America and they all brought these posters with them in terms of the research that they've they'd been doing so they had an opportunity to see what everyone was up to and I'll never never forget this guy who sort of came in a bit flustered, probably
16:55
Unidentified speaker (speaker_3): about an hour late to the conference. And I was like, How are you okay? He's like, I'm just a bit tired. I just got off a flight from Japan, which was thirty hours. I was like, Okay, you here for long? He's
17:04
Unidentified speaker (UNKNOWN): like,
17:04
Unidentified speaker (speaker_3): uh just today and I'm going back tomorrow And I'm just like
17:08
George Walker: Wow So he it was there was sufficient appeal of this conference
17:11
Unidentified speaker (UNKNOWN): that
17:11
George Walker: he he flew for sixty combined hours for a twenty four hour slot.
17:15
Unidentified speaker (speaker_3): Yeah. And then you have the conversations sort of on the last day where everyone's a little bit more relaxed having a couple of drinks, but how it how invaluable they all said it was just to get everyone together in one room and how much they can take out of that and the new relationships that they can build and it's only going to be of benefit not just to all port but kidney disease
17:35
Unidentified speaker (speaker_3): in general as well. So it was a m it was honestly amazing. And all I would also say is from a selfish point, as a volunteer, you come away feeling pretty happy with yourself. Because you do. I mean it you know you've got a real skip in your step after this feeling like you've actually really sort of helped at a sort of an event and and made a bit of a difference.
17:55
Susie Gear: Contributors,
17:56
Unidentified speaker (UNKNOWN): I think yes
17:57
Unidentified speaker (speaker_3): and
17:57
Unidentified speaker (UNKNOWN): you
17:57
Will Shoebotham: do
17:58
George Walker: a different sort of reward isn't it? it? 'Cause Because you and I spend all our lives earning fees and suddenly you you you you have you a beer at seven of the night thinking I've worked really hard today and something else has come out of it.
18:06
Unidentified speaker (speaker_3): Yeah, yeah, yeah. So no, I mean honestly, I've
18:09
Unidentified speaker (UNKNOWN): uh I
18:10
Unidentified speaker (speaker_3): really enjoyed it. Like I I genuinely loved it.
18:13
Unidentified speaker (UNKNOWN): And
18:13
Unidentified speaker (speaker_3): I'll be at the uh at the one next year as well.
18:14
Unidentified speaker (UNKNOWN): Yeah, you
18:15
George Walker: booked in Sao Paulo, we shouldn't have told him about South America. Yeah,
18:17
Unidentified speaker (UNKNOWN): I know. So
18:18
George Walker: all this costs money. Um and and what people like are all sorts sort of fundraising has is allowed is because because the the charity gets people there who can't afford it. which is a the inclusivity thing, isn't it?
18:29
Susie Gear: Yeah. So the r the really important thing to underbow uh understand about rare kidney disease is that probably the majority of the cases are in low resource settings around the world. So we're all sitting in very privileged situation with the m amazing NHS, but most of kidney disease and the people who are living with it
18:49
Susie Gear: are are in situations where they can't afford to even get tested and get diagnosed. In fact, often the countries like Indonesia, which have one of the largest populations, don't even have genetic testing.
19:01
Unidentified speaker (UNKNOWN): Which
19:01
George Walker: is the holy grail of
19:03
Unidentified speaker (UNKNOWN): diagnosing people. Yeah. So
19:04
Susie Gear: you have these poor families who think they have it, so they connect with us through social media and understand the symptoms, etc., but they don't have the money or the technology.
19:15
Susie Gear: to get a diagnosis. And it's really, well, we all know that anxiety is caused by you know something out of control. And when you get a diagnosis it really helps you understand your condition better.
19:28
Unidentified speaker (UNKNOWN): It
19:28
George Walker: clarifies you things. So coming back to money, all SOPs are on a 12-month shove for all Allport. port. Um, How did this start? What do the events look like? Give us some i idea of how that sort of feels amongst the firm now. Because
19:40
Unidentified speaker (UNKNOWN): I think
19:40
George Walker: the first thing was a spinning class, wasn't it?
19:42
Unidentified speaker (speaker_3): Yeah, so the first thing was so each sort of sub team arranges an event or events throughout the year. The first one was a spinning class, I think, in the city. And I mean that alone, I mean what I'm constantly amazed by is that how generous people not just within the business are, but our clients as well. A lot of our clients we've been dealing with for, you know, yourself
20:02
Unidentified speaker (UNKNOWN): twenty
20:02
Unidentified speaker (speaker_3): twenty years. me sort of ten, fifteen, you probably thirty years in some cases. And you get to know these guys so well and we do so much for them and you forget that we don't ask for a lot in return. And sometimes when you do sort of put your hand out for a charitable cause, they're only too willing to be generous. And at Uh this spin event, you know,
20:22
Unidentified speaker (speaker_3): we had a certain client who pitched up with a check cheque for ten thousand pounds.
20:26
Unidentified speaker (UNKNOWN): Yeah.
20:26
George Walker: And and what was interesting to me is I mean I was pretty uh I welled up actually.
20:31
George Walker: But the the eight people that came to that spinning class were just so excited.
20:35
Unidentified speaker (UNKNOWN): They
20:35
George Walker: just were over the moon to be able to make such a difference on this little old charity, which is good. And so what um other things are happening wasn't there a wet walk recently?
20:43
Unidentified speaker (UNKNOWN): Yeah,
20:43
Unidentified speaker (speaker_3): so look, we've done all sorts so walking's always uh
20:47
Unidentified speaker (UNKNOWN): a
20:47
Unidentified speaker (speaker_3): good thing for each of the teams to do 'cause do because it means everyone can get involved. And our leads office, I mean, God, one hell of a challenge. They did a hundred kilometres in twenty-four hours, which you sort of participated within. And
21:00
Susie Gear: it's astounding.
21:01
Unidentified speaker (speaker_3): Honestly, and and the conditions, the weather conditions were against them. So
21:06
Unidentified speaker (UNKNOWN): it
21:06
George Walker: reminded me, wasn't it, the driest summers in 1863?
21:08
Unidentified speaker (UNKNOWN): Yeah,
21:09
Unidentified speaker (speaker_3): until they uh set off. Yeah.
21:11
Unidentified speaker (UNKNOWN): Well no, I
21:12
Unidentified speaker (speaker_3): think it was fine in the day, but then at night I think I've seen some of the videos, the wind and the horizontal rain, and you know, I think so the plan was the Leeds office is probably about um probably about forty of them. And there was a core group that wanted to do the whole sort of hundred kilometres, and I think about six of them completed it from start to finish, and you
21:32
Unidentified speaker (speaker_3): went up there, George, and and you helped out and others sort of partook sort of for part of the walk. But
21:37
Unidentified speaker (UNKNOWN): in order
21:37
Unidentified speaker (speaker_3): to do a hundred kilometres you need a support group and network around you, you know, just feeding you and you know, giving you some dry clothes and you know, and and actually just getting you through it, a bit of a morale boost along the way. So I think you were in a half the night
21:51
Unidentified speaker (UNKNOWN): driving
21:51
Unidentified speaker (speaker_3): round
21:51
George Walker: I'm still reading from the shock of it and and and one of the one of the guys left Leeds at six A. M. to come to London to meet a client to go back to Leeds to get his walking kit on and the client was a bit demanding. Didn't get to the hills till ten to eleven at night in the pouring rain and you walked all the way through till the morning. I mean, that that was
22:10
Susie Gear: That's astounding. And honestly, we're so grateful for that. It's incredible.
22:14
George Walker: It's part of what this sort of group mentality, it's having one call to support. It's really and and everybody in the last two weeks has uh who I've seen and has just asked a question about it because there is this bond that's that's beginning to really become quite a surge of interest in in this rare disease because it means something to the business.
22:30
Unidentified speaker (speaker_3): And it's yeah, and like you say, it's a camaraderie that you sort of go through when in any ch y any challenge that you set in terms of like a endurance event. Like you all come together and you'll have met people in the Leeds office that you probably didn't really know that well. And
22:43
Unidentified speaker (UNKNOWN): you
22:43
Unidentified speaker (speaker_3): know, and and a lot of people have now met you and they I don't want to uh big you up too much but what legend George was on the day just helping us all through it. So you know, it creates this bond as well. And I think that's the other thing when you know you are raising money for charities, when whether the events be you know, paddle events, we've had football tournaments. We had a football tournament last week actually, which is brilliant, because it brings everyone together and you're
23:03
Unidentified speaker (speaker_3): outside of work, and I think it's not just beneficial to the charity that you're raising money for, but also the comp com our company as well, you know, bringing everyone together on a different setting which isn't necessarily work worth or we're in the pub. or wherever we might be. It's only got sort of plus size really to to doing this.
23:19
Will Shoebotham: It's evidence to me that Orpsop has an incredible community of people. And it really is something different
23:27
Unidentified speaker (UNKNOWN): to
23:28
Will Shoebotham: other firms that are doing perhaps the same thing in business. But there's you've got this in this passion and this this sense of community
23:35
Unidentified speaker (UNKNOWN): that has
23:35
Will Shoebotham: kept you on this on this road to raising so much.
23:39
Unidentified speaker (UNKNOWN): Yeah.
23:39
Unidentified speaker (speaker_3): No, well and we enjoy it. We really do. So we're doing actually so the team I'm in with we've got a marathon. We're walking a marathon again, just 'cause it's inclusive and actually I couldn't run one anyway. Um but
23:51
Unidentified speaker (speaker_3): um so we're walking a marathon next week. Starting Barnes, finishing Barnes and Richmond Teddington all around. So
23:59
Unidentified speaker (UNKNOWN): and it
23:59
Susie Gear: you know the the combined value of the team building aspect. But but also I can't tell you how much it raises the profile of
24:08
Unidentified speaker (UNKNOWN): all
24:08
Susie Gear: port too, because when you have this rare disease, nobody knows anything
24:12
Unidentified speaker (UNKNOWN): about it. And
24:12
Susie Gear: it's very hard because other people uh are not aware of it at all. So actually raising the profile, because all port is actually a lot more common, we now know from
24:22
Unidentified speaker (UNKNOWN): research.
24:22
Susie Gear: So it's one in one 100 hundred in any population have a genetic variant. So we really need to raise the profile so that more people get diagnosed because there are a lot of people out there. So you know, doing your fundraising efforts to raise the profile is phenomenal.
24:36
George Walker: And I mean, one of the earliest impacts of the all sort fundraising was the films I think you had commissioned on the patient life.
24:42
Susie Gear: Yeah, no, absolutely. So one of the key ways of of actually explaining what Allport is all about is we've got an amazing filmmaker who has. Allport himself and he creates these great films about what it's like to live with Allport. So when we go to a different country, he goes and films people living with Allport. So we've got a
25:02
Susie Gear: fantastic collection of videos thanks to All Sops.
25:05
Unidentified speaker (UNKNOWN): The All
25:05
George Walker: Sop collection, I think, isn't it?
25:07
Unidentified speaker (UNKNOWN): It is. Um
25:07
Susie Gear: the the initial fundraising has contributed to four wonderful videos that we must attach to this podcast. Yeah,
25:14
George Walker: so we can put them on the episode notes just to be get to see what it means. Where which countries are we talking? Hungary?
25:20
Susie Gear: We filmed in Italy, Hungary, and Spain.
25:23
George Walker: Okay.
25:24
Unidentified speaker (UNKNOWN): And
25:24
George Walker: that is part of the globalisation, is is connecting.
25:27
Susie Gear: And and understanding the differences between the different countries too, because they all have different health systems and different issues that they're dealing with, living with all or port.
25:35
George Walker: It occurs to me that the level of application of things like genetic testing, it doesn't matter. necessarily the
25:41
George Walker: size of the economy. Just there's a pot as a public policy. Singapore does have genetic testing.
25:46
Unidentified speaker (UNKNOWN): Yes, one of our
25:47
Susie Gear: lovely professors has just got to
25:48
Unidentified speaker (UNKNOWN): be able to do that.
25:54
George Walker: And genetic testing is the beginning of understanding this rare disease or any rare disease.
26:00
Susie Gear: And and in fact, it's one of the things that we and as a small rare disease can advocate for the entire uh kidney community because actually genetic testing is really important for lots of other rare kidney diseases. So Ulport is at the forefront of trying to get genetic testing into countries around the world. So our lovely
26:20
Susie Gear: professor in Australia got genetic testing agreed by the government as something for people. Our lovely professor in Singapore as well. Our amazing woman in Indonesia that I mentioned earlier, she's incredible, so they can't afford it. But she hops on a plane on her weekend and she goes to Japan with her
26:40
Susie Gear: samples and she does her genetic testing with our team in Japan and then takes them back and and diagnoses the family. in the
26:47
Unidentified speaker (UNKNOWN): world. Because that's where
26:48
George Walker: she learnt.
26:48
Susie Gear: Yes.
26:49
Unidentified speaker (UNKNOWN): So
26:49
Susie Gear: And that's part of the collaboration. that we've created is to try and get the different countries to collaborate and work together. So you know that's the huge power of events like Budapest
26:59
Unidentified speaker (UNKNOWN): that
27:00
Susie Gear: you came to is getting everybody in a room and getting all the countries working together. It's accelerating the ability to diagnose um people and manage the science.
27:09
George Walker: Super look we've covered a lot of ground. I think we're probably there and we had a a very powerful patient link on one of the days in Budapest talking
27:17
Unidentified speaker (UNKNOWN): about the
27:18
George Walker: first decades hard.
27:22
Unidentified speaker (UNKNOWN): The
27:22
George Walker: second decade, Susie?
27:24
Susie Gear: Well, I I uh he did tell me that the second decade would be easier because of the investment that we've made in the first decade. Uh certainly now we've got treatments in development. It's attracting many more companies, but of course we need more money to support the global network that's um developing the treatments and knowledge.
27:45
George Walker: And what strikes me is that things like genetic testing for Allport means that a lot of other genetic diseases are taken in and
27:53
Unidentified speaker (UNKNOWN): analyzed.
27:54
George Walker: It's not just all port's waving this flag noisily,
27:57
Susie Gear: yeah,
27:57
George Walker: in a very irritating way, in the nicest possible way, but it's taking a lot of other kidney disease, but also rare diseases.
28:03
Unidentified speaker (UNKNOWN): It's
28:04
Susie Gear: taking rare kidney
28:05
Unidentified speaker (UNKNOWN): disease.
28:07
Susie Gear: Well one of the amazing things I had a great conversation with at the end of Budapest with a pharma company from Sweden. And what he his sort of aha moment was that a lot of the treatments that are being developed for all port are not specific to all port. So actually the work that we're doing will help a lot. of
28:27
Susie Gear: the uh rarer diseases as well, as well, and also transplanted kidneys. So it was one of the things that he was telling me was that uh some of the treatments that they're considering putting into clinical trials will also help transplanted kidneys. So it really made it feel worthwhile, all that effort getting everybody together because it will help a
28:47
Susie Gear: much bigger community.
28:48
George Walker: Which is tremendous. Well, thanks to all. AllSOP and thank you for your efforts in driving the message and motivating those teams of people in in the business and making it competitive but friendly competitive.
29:01
Unidentified speaker (speaker_3): No, it's been a pleasure.
29:02
George Walker: Well, good luck in your marathon. Um Susie, may the next decade be even better than the first.
29:06
Susie Gear: Well, thank you to AllSOP too for giving us a bit of a kickstart. And all your lovely clients. Oh
29:12
Unidentified speaker (UNKNOWN): my goodness, so I'm
29:13
Susie Gear: bowled over by their
29:14
Unidentified speaker (UNKNOWN): contract. contributions. Thank you.
29:15
Susie Gear: And
29:16
George Walker: Patrick, we're looking forward to the Hackney Half Marathon, I think, in March, I mean, next year.
29:19
Will Shoebotham: Next year, yes.
29:21
George Walker: So it just shows what can be done. So thank you all, and I hope that's been a useful session.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.
All insights